TMDX(TMDX)
TMDX
ANALYST COVERAGE12 analysts
BUY
▲ +89.5%upside to target
L $85.00
Med $129.50consensus
H $142.00PRICE
Prev Close
63.20
Open
63.83
Day Range63.75 – 68.89
63.75
68.89
52W Range60.11 – 156.00
60.11
156.00
9% of range
VOLUME & SIZE
Avg Volume
1.2M
FUNDAMENTALS
P/E Ratio
15.6x
EPS (TTM)
—
Div Yield
No dividend
Beta
2.03
High vol
TECHNICAL
RSI (14)
18
Oversold
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 105 days
Aug 31
Key MetricsTTM
Market Cap$2.36B
Revenue TTM$635.89M
Net Income TTM$171.92M
Free Cash Flow$151.36M
Gross Margin59.1%
Operating Margin14.9%
Net Margin27.0%
Return on Equity41.9%
Return on Assets12.0%
Debt / Equity1.66
Current Ratio6.74
EPS TTM$5.00
TMDX News
About
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.
Sector
Industry
Surgical and Medical Instrument Manufacturing
Website
Tamer I. KhayalSenior Vice President of International
Waleed H. HassaneinFounder, President, Chief Executive Officer & Director
Anil RanganathAdvisor
Gerardo HernandezChief Financial Officer & Treasurer
Matthew ForsythSenior Vice President, General Counsel & Corporate Secretary
Nicholas CorcoranSenior Vice President of Supply Chain & Operations
Miriam C. ProvostVice President of Global Regulatory Affairs